NIH Director Dr. Francis Collins and other NIH leaders outline efforts to rapidly scale up U.S. COVID-19 testing capacity through its Rapid Acceleration of Diagnostics (RADx) Initiative in an article in the New England Journal of Medicine. RADx was established to fulfill the urgent need for easy, quick, point-of-care testing for SARS-CoV-2, the virus that causes COVID-19. RADx also aims to ensure that testing is available to diverse, vulnerable, and underserved populations that are disproportionately affected by the virus.
Learn more about NIH’s efforts in this area by reading the NEJM paper, the NIH media availability, and the NIH RADx webpage.
Learn more about NIH’s efforts in this area by reading the NEJM paper, the NIH media availability, and the NIH RADx webpage.
.png)
No hay comentarios:
Publicar un comentario